Skip to main content

Surrozen, Inc S-3, filed Nov 18, 2026

Surrozen, Inc. (SRZN)

Surrozen registers resale of up to 5,741,605 common shares, 2,456,500 pre-funded warrant shares and 4,099,052 Series E warrant shares, bought in an October 20, 2026 tranche of its private placement for approximately $95.1 million gross. The company receives no resale proceeds, but would receive approximately $47.3 million if all warrants are exercised for cash. Proceeds are intended for development of SZN-8141 and SZN-8143. AI summary

S-3 2026-11-18
View Original
Added on November 18, 2026